TrialJAMA internal medicine2021

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

Olivier Hermine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.